Sat.Sep 05, 2020 - Fri.Sep 11, 2020

Studies of AstraZeneca coronavirus vaccine put on hold for safety review

Bio Pharma Dive

A participant in a clinical trial of the experimental shot suffered from an unexplained illness, triggering an investigation and a pause in vaccinations

Prescription Digital Therapeutics: When Software Is the Active Ingredient

Camargo

With smartphones now ubiquitous, interest has increased in digital health solutions such as telemedicine platforms. The post Prescription Digital Therapeutics: When Software Is the Active Ingredient appeared first on Camargo. Blog Combination Products Device

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

National parks preserve more than species

Scienmag

Study of Costa Rican rainforest shows national parks are more resilient than expected Credit: Jeff Fitlow/Rice University HOUSTON – (Sept.

AstraZeneca CEO Says COVID-19 Vaccine Trial Pause is the Second Since July

BioSpace

In July, the study was paused after another patient experienced neurological issues

How biotech and pharma companies pay their CEOs, and their workers

Bio Pharma Dive

The median CEO of 231 drug companies analyzed by BioPharma Dive earned 50% more last year than in 2017, a leap that far outpaced the more modest pay gains among employees

Honeybee venom kills aggressive breast cancer cells: Australian study

BioPharma Reporter

Venom from honeybees has been found to rapidly destroy triple-negative breast cancer and HER2-enriched breast cancer cells â with minimal effect on healthy cells, according to a study published this month. Bio Developments

More Trending

Preclinical Data Supports Efficacy for Pfizer, BioNTech Phase II/III COVID-19 Vaccine

BioSpace

Preclinical data for Pfizer and BioNTech’s Phase II/III COVID-19 mRNA vaccine candidate generated BNT162b2 strong anti-viral effects against an infectious SARS-CoV-2 challenge

The voice of the customer, and how pharma can respond

Bio Pharma Dive

ZS surveyed more than 500 physicians, 500 patients and 30 healthcare administrators to gather their current thoughts on care delivery, telemedicine and pharma's potential role during the COVID-19 pandemic

243
243

FSD Pharma announces Phase II trial for potential COVID-19 treatment

Outsourcing Pharma

The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus. COVID-19

Drugs 102

A new twist on DNA origami

Scienmag

DNA 77

Poll: Trust in Fauci and the CDC is Declining Ahead of the November Election

BioSpace

Six months into a global pandemic and public trust is waning in its support for public health officials in charge of the nation’s response to the novel coronavirus, according to a new poll

104
104

FDA wants more details on Sarepta gene therapy, potentially delaying final test

Bio Pharma Dive

A new request from the regulator could tighten the race between Sarepta and Pfizer to prove out a gene therapy for Duchenne muscular dystrophy

Spotlight on Moderna funding declarations in patent filings

BioPharma Reporter

Two US government agencies are investigating whether Moderna Therapeutics, the biotech company behind one of the leading Covid-19 vaccine candidates, was upfront about government funding in its filed or awarded patents, as required by federal law. Markets & Regulations

Bending the curve of biodiversity loss

Scienmag

Credit: IIASA Plant and animal species across the world are steadily disappearing due to human activity.

75

Merck Makes Headway with V114 Vaccine Against Pneumococcal Disease

BioSpace

Merck, known as MSD outside of the U.S. and Canada, announced on Wednesday that it has seen positive results regarding the safety, tolerability and immunogenicity of V114 in two Phase III studies

Sanofi's hemophilia drug comes into focus as delays hit a key competitor

Bio Pharma Dive

With BioMarin's gene therapy sidelined, attention is turning to other drugs, including one Sanofi acquired when it paid $11.6 billion for Bioverativ

Non-vaccine nasal spray could protect against COVID-19

Pharma Phorum

Two UK biotechs – Destiny Pharma and Sporegen – have joined forces to develop a nasal spray that they say could serve as a first line of defense against coronavirus infections.

Common diabetes drug reverses inflammation in the liver

Scienmag

CEOs Pledge to Stand Behind Science, Not Politics in Potential Vaccine Approval

BioSpace

The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Moderna, Novavax, Pfizer, Merck and Sanofi all signed the pledge promising to ensure that any vaccine put forth by one or more of the companies meets the rigorous standards for approval

Coronavirus vaccine makers vow to wait for data before seeking approval

Bio Pharma Dive

In an unusual letter, the heads of nine top vaccine developers pledged to "stand with science" and only move forward with approval applications if warranted by clinical results

NICE turns down Celgene's Revlimid as multiple myeloma maintenance treatment

Pharma Times

The drug's cost-effectiveness estimate when used in the maintenance setting is uncertain, the Institute has concluded

Drugs 91

Scientists find an enzyme that facilitates grafting between different family species

Scienmag

Scientists found that the tobacco plant Nicotiana can maintain grafts between a broad range of species. Using Nicotiana as an intermediary, they succeeded in indirectly grafting a tomato scion and a rootstock of Florist’s daisy, which bore a small fruit.

NeuroOne’s Thin-Film Electrode Technology Offers Less Invasive Solution for Brain Surgery

BioSpace

For patients with epilepsy, the diagnosis and treatment process can be long, arduous, and filled with lengthy hospital stays. The medical device company NeuroOne Medical Technologies Corporation hopes to change that

103
103

Intra-Cellular roars back on success in bipolar depression

Bio Pharma Dive

Widening the number of eligible patients could make Intra-Cellular's schizophrenia pill a blockbuster, analysts forecast

198
198

BCG-COVID 19 Hackathon: Task 1 winners announced, Task 2 – data scientists – we need you!

Pharma R&D Today

We’ve seen the scientific community come together time and again throughout the COVID-19 pandemic, and we’re thrilled to have been part of a hackathon bringing together data scientists, epidemiologists and partner organizations focusing on analysing the hypothesis of whether the tuberculosis (TB) vaccine – BCG – could reduce COVID-19 mortality.

Acorn woodpeckers wage days-long battles over vacant territories, radio tag data show

Scienmag

Credit: Neil Losin When acorn woodpeckers inhabiting high-quality territories die, nearby birds begin a battle royal to win the vacant spot. Researchers used radio tags to understand the immense effort woodpecker warriors expend traveling to and fighting in these dangerous battles.

Eli Lilly Reports Positive Results in Phase III Migraine Attack Study

BioSpace

Eli Lilly and Company announced today that it has seen positive results from CENTURION, its Phase III study looking into Reyvow (lasmiditan) for migraine attacks

100
100

Merck takes aim at Pfizer with pneumonia vaccine data

Bio Pharma Dive

Results from two Phase 3 studies put Merck in position to ask for FDA approval of its shot later this year. Pfizer may not be far behind with a rival product

Clinical Outcomes in Young US Adults Hospitalized With COVID-19

JAMA Internal Medicine

This case series examines the clinical outcomes for young adults hospitalized with COVID-19

63

Unraveling the secrets of Tennessee whiskey

Scienmag

Food scientists with the UT Institute of Agriculture tackle the science of flavor Credit: Photo by J. Munafo, courtesy UTIA. KNOXVILLE, Tenn.

Feline Antiviral Therapy Shows Promise Against SARS-CoV-2 in Human Cells

BioSpace

A study published in Nature Communications on August 27 shows that a feline antiviral drug was effective at inhibiting the replication of human coronaviruses in cell cultures infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2

Drugs 101

NIH starts broad set of studies testing blood thinners against COVID-19

Bio Pharma Dive

The trials, which involve Bristol Myers and Pfizer's Eliquis as well as other anticoagulants, follow mounting evidence of blood clotting in COVID-19 patients

Trials 168

How companies can encourage more diversity and inclusion in pharma

Pharma Phorum

September is Global Diversity and Inclusion month – David Peacock, managing director of MSD in the UK shares with us his insights on why diversity and inclusion is so important and why it is critical to the future success of the life sciences sector.

US democratic indicators plummet amid racial justice protests and pandemic

Scienmag